The first oral antiviral medication to treat COVID-19 is one step closer. Tuesday, November 30 a Food and Drug Administration (FDA) advisory panel voted to recommend Merck's request for emergency use authorization of its drug, molnupiravir.

"If and when one or both of these drugs is approved, that's going to change the way we treat COVID-19 infection for outpatients," says Dr. Andrew Badley, a Mayo Clinic infectious diseases physician. https://mayocl.in/3xH8a5O